Eric Loudermilk, MD
Anesthesiology · Anderson, SCNPI 1225075088
Payments from drug & device makers
Across 1,607 payments — averaging $1774.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2.6M
- Avanos Medical$144K
- Regeneron$104K
- GRT US Holding, Inc.$31K
- Forte Bio-pharma LLC$2K
- Pacira Therapeutics, Inc.$2K
- plus $10K from 51 others
Across 4 payments — averaging $6756.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$27K
What the payments were for
- Food & beverage$21,408100%
- Education$120%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Prolate$2,559
- Zilretta$1,696
- GENERAL PAIN MANAGEMENT$1,150
- WaveWriter Alpha Prime 16$1,065
- Nalocet$921
- SPECTRA WAVEWRITER$482
- WAVEWRITER ALPHA$222
- AJOVY$218
- VANTA ADAPTIVESTIM$196
- GENERAL - THERAPIES$155
- TANLOR$150
- Nucynta ER$148
- NucyntaER$127
- QULIPTA$122
- UBRELVY$122
- AIMOVIG$114
- Qutenza$114
- INCEPTIV$104
How this compares
$2,851,502 in reported general payments places this provider in the 95th percentile of 609 anesthesiology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 579 | $409,509 |
| Nucynta ErTapentadol Hcl | 184 | $267,775 |
| NucyntaTapentadol Hcl | 155 | $223,551 |
| OxycontinOxycodone Hcl | 115 | $85,340 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 3,266 | $81,288 |
| ProlateOxycodone Hcl/Acetaminophen | 23 | $77,736 |
| Xtampza ErOxycodone Myristate | 108 | $75,183 |
| Oxycodone Hcl | 1,756 | $41,425 |
| BelbucaBuprenorphine Hcl | 21 | $13,520 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 123 | $13,315 |
| ZtlidoLidocaine | 23 | $12,735 |
| Morphine Sulfate ErMorphine Sulfate | 245 | $10,578 |
| Fentanyl | 84 | $10,145 |
| MovantikNaloxegol Oxalate | 20 | $7,936 |
| Celecoxib | 399 | $6,513 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta Er, Nucynta, Xtampza Er, Belbuca | $897 | $580,030468 claims |
| Forte Bio-pharma LLCProlate | $2,280 | $77,73623 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $1,715 | $12,73523 claims |
| Redhill Biopharma Inc.Movantik | $100 | $7,93620 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 609 anesthesiology providers in South Carolina.
Other anesthesiology in Anderson
- Blake LecheAnderson$13K
- William HandGreenville$510K
- Frank OverdykCharleston$131K
- Frank HumblesConway$74K
- Joseph RodrigoCharleston$54K
- Jeffrey FrohockCharleston$48K
- David ArcellaCharleston$18K
- David HallGreenville$16K
- Metul ShahCharleston$11K
- Devin AntonovichWest Columbia$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.